The results of this study showed that the total therapeutic effective rate, LH, FSH, E2 level, Kupperman score of Kuntai capsule, and Climen group were more effective than those of the Climen group in the treatment of premature ovarian failure. The gene discussed is BRD2; the disease is primary ovarian failure.